Mira PharmaceuticalsMIRA
13F holders, Q3 2024 (September 30)15holders +4
7new positions
3sold out
1famous investor
$1.30avg. 13F price*
At the end of Q3 2024, 15 institutions reported holding Mira Pharmaceuticals Inc. (MIRA) in their 13F filings, up 4 from Q2 2024. 7 opened new positions and 3 sold out. The largest holders were Cross Staff Investments Inc ($476K), Geode Capital Management, LLC ($151K) and Suncoast Equity Management ($117K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Mira Pharmaceuticals Inc.
- CUSIP
- 60458C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $342K |
| Exits | 3 | $48K |
All 13F filers, Q2 2024 → Q3 2024: 312,813 shares bought and 194,429 shares sold, net +118,384 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Cross Staff Investments Inc | 0.37% | Reduce -4.6% | 365,901 | $476K |
| Geode Capital Management, LLC | 0.00% | New | 115,914 | $151K |
| Suncoast Equity Management | 0.01% | Add +125.0% | 90,000 | $117K |
| LPL Financial LLC | 0.00% | New | 50,000 | $65K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 41,900 | $54K |
| Millennium Management | 0.00% | New | 40,725 | $53K |
| Avantax Planning Partners, Inc. | 0.00% | Reduce -73.0% | 32,000 | $42K |
| Northern Trust Corp. | 0.00% | Reduce -1.6% | 20,124 | $26K |
| First American Bank | 0.00% | No change | 20,000 | $26K |
| Praetorian Wealth Management, Inc. | 0.01% | Reduce -36.4% | 17,500 | $23K |
| Jane Street Group, LLC | 0.00% | New | 12,186 | $16K |
| Two Sigma Securities, LLC | 0.00% | Reduce -33.0% | 11,964 | $16K |
| Cary Street Partners Investment Advisory LLC | 0.00% | No change | 10,000 | $13K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 2,000 | $3K |
| Bank of America Corp. | 0.00% | New | 88 | $114 |
"% of holder's portfolio" is MIRA's weight in each manager's 13F, not the share of Mira Pharmaceuticals Inc. the manager owns.